Curr Opin Neurol. 2011 Jun;24(3):262-7. doi: 10.1097/WCO.0b013e328346d2a3.
The appearance of progressive multifocal leukoencephalopathy (PML) in association with newer, highly effective biological agents has increased the importance of understanding the mechanisms by which they and other underlying predisposing causes give rise to the disorder. This review attempts to describe what is currently known about the pathogenesis of PML.
JC virus is a ubiquitous polyoma virus that infects at least 50% of the human population by adulthood. Despite this high prevalence of infection PML remains exceptionally rare, suggesting the presence of multiple high barriers to its development. Proposed barriers include host, viral, and immunological factors. With respect to host factors, no data is presently available. A viral barrier exists if the initial infection is with the archetype JC virus which requires genetic rearrangement of its promoter region to enable effective replication in oligodendrocytes. Cell-mediated immunity, in particular, JC virus-specific cytotoxic T cells, appears to be the most important recognized immunological barrier but likely not the only one.
There remain significant gaps in our understanding of JC virus biology and PML pathogenesis. However, the present state of knowledge provides a framework for the generation of coherent and reasonable hypotheses. A better understanding of these disease mechanisms will improve our ability to both predict and mitigate the risks for the development of PML associated with various predisposing diseases and therapies.
与新型高效生物制剂相关的进行性多灶性白质脑病(PML)的出现,增加了了解它们和其他潜在致病原因导致该疾病的机制的重要性。本综述试图描述目前已知的 PML 发病机制。
JC 病毒是一种普遍存在的多瘤病毒,在成年期至少感染了 50%的人口。尽管感染率如此之高,但 PML 仍然极为罕见,这表明其发展存在多个高障碍。拟议的障碍包括宿主、病毒和免疫因素。就宿主因素而言,目前尚无数据。如果初始感染是原始 JC 病毒,则存在病毒障碍,原始 JC 病毒需要其启动子区域的遗传重排才能在少突胶质细胞中有效复制。细胞介导的免疫,特别是 JC 病毒特异性细胞毒性 T 细胞,似乎是最重要的公认免疫障碍,但可能不是唯一的障碍。
我们对 JC 病毒生物学和 PML 发病机制的理解仍然存在重大差距。然而,目前的知识状况为形成一致和合理的假设提供了框架。更好地了解这些疾病机制将提高我们预测和减轻与各种易患疾病和治疗相关的 PML 发展风险的能力。